The team will employ reverse vaccinology coupled with high-throughput genomics approaches, such as RNA-seq, to deliver the new vaccines within four years.
Applied Markets News: Life Tech, Copan Flock Pact; Applied Genetics' Johne's Disease Partnership
Life Technologies said this week that it has signed an agreement with Copan Flock to provide an integrated, end-to-end system for DNA forensics.
Mexican University to Validate GeneThera Platform for Johne's Disease
NEW YORK (GenomeWeb News) – GeneThera announced today that its wholly owned subsidiary Applied Genetics has signed a deal with the Universidad National Autonoma de Mexico to validate GeneThera's platform for Johne's disease.
GeneThera is currently negotiating formal licensing agreements with the Universita di Roma "Tor Vegata" and Universita Cattolica del Sacro Cuore, which have jointly developed a potential liposome-based therapeutic for Johne's disease, an uncurable bacterial disease affecting the intestinal tract of livestock.